Atlas Trials

Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies

Clinical trial NCT04361708 · RECRUITING

Trial details

NCT number
NCT04361708
Sponsor
University of Chicago
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Pancreatic AdenocarcinomaGastroesophageal Junction AdenocarcinomaAdenocarcinoma
Start date
2020-05-08
Primary completion
2026-06-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.